Suppr超能文献

¹⁸F-FDG 主动脉瘤摄取 PET/CT 与未来增长率之间的关系是什么?

What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?

机构信息

Department of Vascular Surgery, Brighton and Sussex University Hospital, Eastern Road, Brighton BN2 5BE, UK.

出版信息

Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1493-9. doi: 10.1007/s00259-011-1799-8. Epub 2011 Apr 6.

Abstract

PURPOSE

In this study we investigate the relationship between (18)F-fluorodeoxyglucose (FDG) metabolism and future aneurysm expansion measured by serial duplex ultrasound. Current screening programmes are increasing the identification of patients with abdominal aortic aneurysm (AAA). The management of these patients remains challenging and methods of risk stratification are sought.

METHODS

Thirty-four consecutive patients [31 men, 3 women, median age 75 years, interquartile range (IQR) 71-78] with aortic aneurysms under routine surveillance with serial ultrasound were prospectively recruited for (18)F-FDG positron emission tomography (PET)/CT. A whole vessel type analysis was performed measuring the highest aortic wall (18)F-FDG uptake (standardized uptake value or SUV(max)), and target to background ratio (TBR) for each axial image and median SUV(max) and TBR value were calculated. Institutional Review Board permission and informed patient consent were obtained.

RESULTS

Nine patients failed to undergo 12-month follow-up study (deceased n = 2, withdrew n = 1, failed to attend ultrasound scan n = 5, emergency aneurysm repair n = 1) leaving 25 patients for analysis. The median whole vessel SUV(max) was 1.70 (IQR 1.45-2.08). The median whole vessel TBR was 1.15 (IQR 1.00-1.40). The median aneurysm expansion at 12 months was 2.0 mm (IQR 0.5-5.0). The correlation (r) between (18)F-FDG SUV(max) and ultrasound expansion at 1 year was -0.501 (p = 0.011).

CONCLUSION

The preliminary findings from this observational longitudinal pilot study suggest that there is an inverse trend between (18)F-FDG uptake on PET and future AAA expansion. Aortic aneurysms with lower metabolic activity may therefore be more likely to expand.

摘要

目的

本研究旨在探讨(18)F-氟脱氧葡萄糖(FDG)代谢与经连续双功超声测量的未来动脉瘤扩张之间的关系。目前的筛查计划增加了对腹主动脉瘤(AAA)患者的识别。这些患者的管理仍然具有挑战性,正在寻求风险分层方法。

方法

连续 34 例(31 名男性,3 名女性;中位年龄 75 岁,四分位距 [IQR] 71-78)接受常规超声监测的主动脉瘤患者前瞻性纳入(18)F-FDG 正电子发射断层扫描(PET)/CT 研究。对整个血管类型进行分析,测量最高主动脉壁(18)F-FDG 摄取(标准化摄取值或 SUV(max))和每个轴向图像的靶标与背景比(TBR),并计算中位数 SUV(max)和 TBR 值。获得机构审查委员会许可和患者知情同意。

结果

9 例患者未能进行 12 个月的随访研究(死亡 2 例,退出 1 例,未进行超声扫描 5 例,急诊动脉瘤修复 1 例),25 例患者进行了分析。整个血管 SUV(max)的中位数为 1.70(IQR 1.45-2.08)。整个血管 TBR 的中位数为 1.15(IQR 1.00-1.40)。12 个月时动脉瘤扩张的中位数为 2.0 毫米(IQR 0.5-5.0)。(18)F-FDG SUV(max)与 1 年超声扩张的相关性(r)为-0.501(p = 0.011)。

结论

这项观察性纵向初步研究的结果表明,(18)F-FDG 摄取与未来 AAA 扩张之间存在反趋势。因此,代谢活性较低的主动脉瘤可能更有可能扩张。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验